Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 65

1.

Saudi lung cancer management guidelines 2017.

AR Jazieh on Behalf of Saudi Lung Cancer Guidelines Association, Saudi Lung Cancer Guidelines Members, Jazieh AR, Al Kattan K, Bamousa A, Al Olayan A, Abdelwarith A, Ansari J, Al Twairqi A, Al Fayea T, Al Saleh K, Al Husaini H, Abdelhafiez N, Mahrous M, Faris M, Al Omair A, Hebshi A, Al Shehri S, Al Dayel F, Bamefleh H, Khalbuss W, Al Ghanem S, Loutfi S, Khankan A, Al Rujaib M, Al Ghamdi M, Ibrahim N, Swied A, Al Kayait M, Datario M.

Ann Thorac Med. 2017 Oct-Dec;12(4):221-246. doi: 10.4103/atm.ATM_92_17.

2.

How Useful Are International Treatment Guidelines in Low- and Middle-Income Countries?

Kerr S, Jazieh AR, Kerr D.

J Glob Oncol. 2017 Jan 18;3(5):441-443. doi: 10.1200/JGO.2016.008250. eCollection 2017 Oct. No abstract available.

3.

Implementation Framework for NCCN Guidelines.

Jazieh AR, McClure JS, Carlson RW.

J Natl Compr Canc Netw. 2017 Oct;15(10):1180-1185. doi: 10.6004/jnccn.2017.7020. No abstract available.

PMID:
28982742
4.

Lymphocyte recovery is an independent predictor of relapse in allogeneic hematopoietic cell transplantation recipients for acute leukemia.

Damlaj M, Ghazi S, Mashaqbeh W, Gmati G, Salama H, Abuelgasim KA, Rather M, Hajeer A, Al-Zahrani M, Jazieh AR, Alhejazi A, Alaskar A.

World J Transplant. 2017 Aug 24;7(4):235-242. doi: 10.5500/wjt.v7.i4.235.

5.

Reducing Central Venous Catheter Use in Peripheral Blood Stem Cell Donation: Quality Improvement Report.

Ghazi S, Alaskar A, Alzahrani M, Damlaj M, Abuelgasim KA, Gmati G, Alshami M, Alshammary S, Al-Surimi K, Salama H, Alhejazi A, Jazieh AR.

BMJ Qual Improv Rep. 2017 Apr 28;6(1). pii: u211975.w4817. doi: 10.1136/bmjquality.u211975.w4817. eCollection 2017.

6.

Health-Related Predictors of Quality of Life in Cancer Patients in Saudi Arabia.

Ahmed AE, Almuzaini AS, Alsadhan MA, Alharbi AG, Almuzaini HS, Ali YZ, Jazieh AR.

J Cancer Educ. 2017 Mar 7. doi: 10.1007/s13187-017-1198-3. [Epub ahead of print]

PMID:
28271388
7.

The predictors of poor quality of life in a sample of Saudi women with breast cancer.

Ahmed AE, Alharbi AG, Alsadhan MA, Almuzaini AS, Almuzaini HS, Ali YZ, Jazieh AR.

Breast Cancer (Dove Med Press). 2017 Feb 9;9:51-58. doi: 10.2147/BCTT.S125206. eCollection 2017.

8.

Improving physician's hand over among oncology staff using standardized communication tool.

Alolayan A, Alkaiyat M, Ali Y, Alshami M, Al-Surimi K, Jazieh AR.

BMJ Qual Improv Rep. 2017 Jan 27;6(1). pii: u211844.w6141. doi: 10.1136/bmjquality.u211844.w6141. eCollection 2017.

9.

An Atypical Initial Presentation of Chronic Myeloid Leukemia with Central Nervous System and Lymph Node Blast Crises.

Abuelgasim KA, Alshieban S, Almubayi NA, Alhejazi A, Jazieh AR.

Case Rep Oncol. 2016 Aug 10;9(2):415-421. eCollection 2016 May-Aug.

10.

192TiP: NEPTUNE: A global, phase 3 study of durvalumab (MEDI4736) plus tremelimumab combination therapy versus standard of care (SoC) platinum-based chemotherapy in the first-line treatment of patients (pts) with advanced or metastatic NSCLC.

Mok T, Schmid P, Arén O, Arrieta O, Gottfried M, Jazieh AR, Ramlau R, Timcheva K, Martin C, McIntosh S.

J Thorac Oncol. 2016 Apr;11(4 Suppl):S140-1. doi: 10.1016/S1556-0864(16)30301-X. Epub 2016 Apr 15. No abstract available.

11.

Patterns of epidermal growth factor receptor mutation in non-small-cell lung cancers in the Gulf region.

Jazieh AR, Jaafar H, Jaloudi M, Mustafa RS, Rasul K, Zekri J, Bamefleh H, Gasmelseed A.

Mol Clin Oncol. 2015 Nov;3(6):1371-1374. Epub 2015 Sep 16.

12.

Health-related quality of life in patients with sickle cell disease in Saudi Arabia.

Ahmed AE, Alaskar AS, Al-Suliman AM, Jazieh AR, McClish DK, Al Salamah M, Ali YZ, Malhan H, Mendoza MA, Gorashi AO, El-Toum ME, El-Toum WE.

Health Qual Life Outcomes. 2015 Nov 16;13:183. doi: 10.1186/s12955-015-0380-8.

13.

Phase II Clinical Trial of Gefitinib for the Treatment of Chemonaïve Patients with Advanced Non-small Cell Lung Cancer with Poor Performance Status.

Karim NA, Musaad S, Zarzour A, Patil S, Jazieh AR.

Clin Med Insights Oncol. 2014 Nov 25;8:121-8. doi: 10.4137/CMO.S15172. eCollection 2014.

14.

Adaptation of NCCN Guidelines to the Middle East and North Africa Region.

Jazieh AR.

J Natl Compr Canc Netw. 2014 Jul;12(7):961-2. No abstract available.

PMID:
24994915
15.

Erlotinib in wild type epidermal growth factor receptor non-small cell lung cancer: A systematic review.

Jazieh AR, Al Sudairy R, Abu-Shraie N, Al Suwairi W, Ferwana M, Murad MH.

Ann Thorac Med. 2013 Oct;8(4):204-8. doi: 10.4103/1817-1737.118503.

16.

The roles of epidermal growth factor receptor (EGFR) inhibitors in the management of lung cancer.

Al Olayan A, Al Hussaini H, Jazieh AR.

J Infect Public Health. 2012 Dec;5 Suppl 1:S50-60. doi: 10.1016/j.jiph.2012.09.004. Epub 2012 Nov 6. Review.

17.

The lung cancer management guidelines 2012.

Jazieh AR; Saudi Lung Cancer Guidelines Committee.

J Infect Public Health. 2012 Dec;5 Suppl 1:S4-10. doi: 10.1016/j.jiph.2012.09.011. Epub 2012 Nov 6. No abstract available.

18.

Saudi Lung Cancer Guidelines update 2012.

Jazieh AR.

J Infect Public Health. 2012 Dec;5 Suppl 1:S11-3. doi: 10.1016/j.jiph.2012.09.012. Epub 2012 Nov 15. No abstract available.

19.

Saudi Lung Cancer Guidelines Supplement 2012. Introduction.

Jazieh AR.

J Infect Public Health. 2012 Dec;5 Suppl 1:S1. doi: 10.1016/j.jiph.2012.09.005. Epub 2012 Nov 6. No abstract available.

20.

Use of complementary and alternative medicine by patients with cancer in Saudi Arabia.

Jazieh AR, Al Sudairy R, Abulkhair O, Alaskar A, Al Safi F, Sheblaq N, Young S, Issa M, Tamim H.

J Altern Complement Med. 2012 Nov;18(11):1045-9. doi: 10.1089/acm.2011.0266. Epub 2012 Aug 20.

PMID:
22906212

Supplemental Content

Loading ...
Support Center